Lecture-240: Update on the Management of Psoriasis. Part -1. 10th edition of Rooks

Lecture-240: Update on the Management of Psoriasis. Part -1. 10th edition of Rooks

🎙 Prof. Asher Ahmed Mashud 👥 20K 📅 August 2, 2026 ⏱ 45 min 👁 300 📄 expert opinion 🧭 2026-08-15
Available in: English (current) Français

Keywords

psoriasismanagementtopical corticosteroidsvitamin D analoguesphototherapy

Summary

This lecture, part of a series based on the 10th edition of Rook’s Textbook of Dermatology, provides an update on the management of psoriasis. The speaker, Prof. Asher Ahmed Mashud, begins by emphasizing the importance of clinical acumen for diagnosis, with skin biopsy and inflammatory markers as adjuncts. He then outlines general management principles, including patient-specific factors like age, gender, and financial resources, and the need for objective severity scoring (PASI, PGA). The lecture covers topical treatments in detail: corticosteroids (potent for thick plaques, mild for sensitive areas), vitamin D analogues (calcipotriol, calcitriol) often combined with betamethasone, and older agents like dithranol and coal tar, noting their declining availability. Newer topical agents like tapinarof and roflumilast are mentioned. Phototherapy is discussed, with narrowband UVB as the preferred first-line for moderate-to-severe cases, and PUVA as an alternative with more side effects. Systemic therapy is introduced, focusing on methotrexate (dosing, monitoring, side effects) and cyclosporine (mechanism, dosing), with mention of acitretin and apremilast. The lecture is interrupted due to technical issues, with a promise to continue next week.

176 words

Critical Evaluation

Value of the Information & Strength of the Argument

The lecture provides valuable, up-to-date information on psoriasis management, drawing from a authoritative textbook. The speaker’s clinical experience adds practical insights, such as the use of methotrexate injections and combination therapies. The argumentation is generally solid, with explanations of mechanisms of action and evidence-based recommendations, though some claims lack specific citations. The discussion of newer agents like tapinarof and roflumilast is timely, but the lecture’s value is somewhat limited by its incomplete coverage (part 1) and the lack of detailed references.

Scientific Rigor, Source Quality, Title Accuracy

The lecture is based on the 10th edition of Rook’s Textbook of Dermatology, a well-regarded reference, lending credibility. However, the speaker does not provide specific citations or URLs for the claims made, relying on his expertise and the textbook’s authority. The title accurately reflects the content, which is an update on psoriasis management. The lecture’s rigor is moderate: it is an expert opinion rather than a systematic review, and some statements are anecdotal (e.g., personal experience with coal tar). The lack of explicit sources limits verifiability, but the content aligns with established dermatological guidelines.

190 words

Title / Content Match

The title accurately reflects the content, which is an update on psoriasis management based on the latest edition of Rook's textbook.

Quality & Reliability

7/10

The lecture is based on the 10th edition of Rook's Textbook of Dermatology, a reputable source, and delivered by an experienced dermatologist. However, it is an expert opinion with limited peer-reviewed references and some personal anecdotes.

Key Moments

Cited Sources

  • Rook's Textbook of Dermatology, 10th Edition — The lecture is based on this textbook, which is the primary source for the content.

Concurring Sources

  • Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies — This guideline supports the use of topical corticosteroids and vitamin D analogues as discussed in the lecture.
  • British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for the treatment of skin disease — These guidelines align with the lecture's recommendations on methotrexate dosing and monitoring.

Dissenting Sources

Contribution & Novelties

The lecture provides an update on psoriasis management based on the latest edition of Rook’s textbook, highlighting new topical agents like tapinarof and roflumilast, and emphasizing the shift towards narrowband UVB as first-line phototherapy. It also discusses the evolving role of methotrexate in combination with biologics. The speaker’s clinical experience adds practical tips, such as using subcutaneous methotrexate for better tolerance.

Pour aller plus loin :

  • Psoriasis - World Health Organization — Official WHO fact sheet on psoriasis, providing global context and management overview.
  • Tapinarof - FDA approval — FDA announcement of tapinarof approval for plaque psoriasis, relevant to the novel topical agent discussed.
  • Roflumilast - PubMed article — A study on roflumilast cream for psoriasis, supporting its efficacy and safety.
  • Narrowband UVB therapy - DermNet NZ — Comprehensive overview of narrowband UVB, including indications and protocols.
  • Methotrexate in psoriasis - British Association of Dermatologists guidelines — Guidelines on methotrexate use, including monitoring and safety.

155 words

Radar Profile

The radar profile shows high scores in quantity of information and technical level, indicating a detailed and specialized lecture. The quality of information and global reliability are slightly lower, reflecting the reliance on expert opinion and lack of explicit citations. The lecture is well-suited for dermatology professionals seeking an update.

Reliability 7/10

💬 Sur les 0 commentaires analysés, aucune tendance n'est disponible.